Discover various promising treatments in development to address the unmet needs of people with Charcot–Marie–Tooth disease.

Vermont forests are under threat. This includes the plants and animals who call our forests home, as well as our communities that rely on healthy forests for clean drinking water, recreational ...

November is pancreatic cancer awareness month as survivors and advocates highlight the disease. It accounts for 3 percent of ...

Doctors warn shiny leg skin can be a sign of peripheral artery disease. The condition causes a build-up of fatty deposits in ...

Worried about your risk of developing type 2 diabetes? According to a new study, you might want to keep an eye on the type of ...

Used in conjunction with the oral sonosensitizing agent 5-ALA, the sonodynamic therapy led to a median OS of 15.7 months in ...

The engineered cells could help researchers understand how cells work together and trace the origins of certain illnesses ...

A new study suggests that 40% of American adults have conditions that could benefit from semaglutide treatment.

Ohio’s weeklong deer gun hunting season begins Monday, Dec. 2, according to the Ohio Department of Natural Resources (ODNR) ...

Outlook Therapeutics’ eye disease drug has failed to match Roche’s Lucentis in a key trial. The biotech brushed off the ...

PTC Therapeutics may reeling from the failure of its amyotrophic lateral sclerosis (ALS) drug utreloxastat yesterday, but the ...

A large new population study of men over 45 indicates insulin resistance may be an important risk factor for the development of the world’s most common heart valve disease – aortic stenosis (AS).